Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine growth factor receptors in surrounding tissues refer to a functional class of cell-surface proteins, primarily receptor tyrosine kinases, that mediate communication between different cell types within a local environment (PMID: 25207476). These receptors are expressed on cells such as endothelial cells, fibroblasts, and immune cells, and are activated by growth factors like VEGF, PDGF, or FGF secreted by neighboring cells (Nature Reviews Cancer, doi: 10.1038/nrc1272). In pathological states like cancer, tumor cells exploit these paracrine pathways to stimulate angiogenesis and stromal remodeling, which supports tumor progression and immune evasion (PubMed, PMID: 15057279). Similarly, in fibrotic diseases, paracrine activation of these receptors on fibroblasts leads to excessive extracellular matrix deposition and organ dysfunction. Therapeutic agents, including monoclonal antibodies like bevacizumab and small-molecule inhibitors like nintedanib, target these receptors to disrupt the supportive signaling network of the disease microenvironment (StatPearls, NBK482253). Because this term describes a broad signaling mechanism involving multiple distinct proteins rather than a single molecular entity, it is categorized as a functional group rather than a specific therapeutic target.
Inhibition of receptor tyrosine kinase activity or ligand-receptor binding to disrupt intercellular signaling pathways within the tissue microenvironment.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine growth factor receptor.